Close Menu

Fighting Lupus

MIT's Technology Review reports on a new approach to treating lupus that could reverse the autoimmune disease's effects on the immune system. Two companies — ImmuPharma in London and Cephalon in Pennsylvania — are collaborating to develop an experimental drug called Lupuzor, which has just ended Phase II trials with some promising data, the Review's Arlene Weintraub says. Instead of shutting down the immune system the way chemotherapy does, Lupuzor targets T and B cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.